Kepler Cheuvreux Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy

May 26, 2026 3:55 AM

Kepler Cheuvreux analyst Nicolas Pauillac upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Hold to Buy with a price target of GBP25.16 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found